InvestorsHub Logo
Followers 7
Posts 5499
Boards Moderated 0
Alias Born 09/11/2013

Re: None

Friday, 03/06/2020 2:45:32 PM

Friday, March 06, 2020 2:45:32 PM

Post# of 146240
I'm borrowing these points from another board, but I think they are very valid points, which certainly highlight problems with the "two week and done" Diwan claims which he is using to pump up NNVC during the most recent scare.


1) NNVC doesn't actually have a license from Diwan/Theracour to produce a medicine for this virus or group of viruses at this stage,... and that would have to be 'negotiated' in some way.

2) NNVC doesn't have any actual test data - model organism or otherwise - of which we are aware that indicates that their proposed medicine does anything useful,... so they would have to spend a year or more generating some actual data.

3) NNVC doesn't have any toxicity testing data for an ingested or injected version of any of their drugs,... so they would have to first make enough quantity (this capability is debatable of course) to do toxicity testing and then do the testing.

4) Aren't they actually supposed to be working on clinical testing for their topical anti-shingles treatment currently?


Just because you can doesn't mean you should.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News